MedPath

The Application of Art Therapy to Patients Undergoing Hemodialysis Treatment

Not Applicable
Not yet recruiting
Conditions
Anxiety
Psychological Well-Being
Hemodialysis
Registration Number
NCT07005960
Lead Sponsor
EMİNE İNAL
Brief Summary

Purpose of the Study: This study aims to investigate the effect of art therapy on anxiety and psychological resilience levels in Chronic kidney disease(CKD) patients undergoing hemodialysis patients.

Hemodialysis patients undergo long-term treatment, often experiencing psychological issues such as anxiety and depression, which significantly reduce their quality of life. Among non-pharmacological approaches to alleviate these symptoms, art therapy has gained increasing attention. Art therapy helps patients shift their focus away from their illness, fosters self-confidence, reduces anxiety, and promotes relaxation .

Detailed Description

Preliminary Implementation of the Study Implementation of the Research During the data collection phase of the study, the researcher will explain the purpose of the study to patients who meet the inclusion criteria, provide necessary information, and obtain both verbal and written informed consent. After the information and consent process, all data in the "Personal Information Form" related to the patient will be filled out by the researcher.

Patients will be divided into two groups: the experimental group (35 participants) and the control group (35 participants). Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again. By this point, each patient will have painted four given pictures and drawn and painted four of their own.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

For the control group (35 participants), during the first week, without any intervention beyond standard clinical procedures, participants will complete the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory. This process will be repeated in the fourth week. One month later, the same scales will be administered again without any intervention.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria

Undergoing hemodialysis for at least 6 months,

Willing to participate in the study,

Aged between 18 and 65 years,

No communication disorders,

No infectious diseases.

Exclusion Criteria

Sensory impairments (vision or hearing loss),

Not willing to participate in the study,

Having an infectious disease.

Independent and Dependent Variables:

Independent Variable: Art therapy. Dependent Variables: Scores from the Brief Resilience Scale and State-Trait Anxiety Inventory (STAI 1-STAI 2).

Control Variables: Participants' sociodemographic characteristics.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Brief Psychological Resilience Scale2 months

Measuring the change in Psychological Resilience Levels through art therapy in patients undergoing hemodialysis treatment.

State And Trait Anxiety Scale2 months

Measuring the change in Anxiety Levels through art therapy in patients undergoing hemodialysis treatment.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath